Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -112,017 | -232,493 | -132,596 | -72,435 | -41,106 |
| Depreciation Amortization | 33,460 | 90,653 | 10,478 | 3,699 | 1,479 |
| Income taxes - deferred | N/A | N/A | 1,760 | -5,777 | N/A |
| Accounts receivable | 4,139 | -2,296 | -2,251 | -493 | 2,087 |
| Accounts payable and accrued liabilities | -3,420 | -1,995 | 1,949 | 6,781 | -1,810 |
| Other Working Capital | 4,401 | -14,770 | -27,939 | -7,652 | -3,440 |
| Other Operating Activity | 4,515 | 35,720 | 23,783 | 3,950 | 4,476 |
| Operating Cash Flow | $-68,922 | $-125,181 | $-124,816 | $-71,927 | $-38,314 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -103 | -1,691 | -2,382 | -822 | N/A |
| Net Acquisitions | N/A | 96 | -30,650 | -49,086 | -2,450 |
| Purchase Of Investment | -233,021 | -111,264 | -84,195 | -313,392 | N/A |
| Sale Of Investment | 306,963 | 137,017 | 200,888 | 86,483 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -102 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -894 | -1,245 | 0 |
| Investing Cash Flow | $73,839 | $24,158 | $82,767 | $-278,062 | $-2,450 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 761 |
| Debt Issued | 18,000 | 80,000 | N/A | N/A | 1,774 |
| Debt Repayment | -66,058 | -9,047 | -36 | -15,005 | -5,000 |
| Common Stock Issued | 41,495 | 56,383 | 23,621 | 352,820 | 68,625 |
| Other Financing Activity | -7,122 | -13,521 | -578 | -1,704 | -4,258 |
| Financing Cash Flow | $-13,685 | $113,815 | $23,007 | $336,111 | $61,902 |
| Exchange Rate Effect | -7 | 65 | -38 | N/A | N/A |
| Beginning Cash Position | 18,348 | 5,491 | 24,571 | 38,449 | 17,311 |
| End Cash Position | 9,573 | 18,348 | 5,491 | 24,571 | 38,449 |
| Net Cash Flow | $-8,775 | $12,857 | $-19,080 | $-13,878 | $21,138 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,922 | -125,181 | -124,816 | -71,927 | -38,314 |
| Capital Expenditure | -103 | -1,691 | -2,408 | -822 | N/A |
| Free Cash Flow | -69,025 | -126,872 | -127,224 | -72,749 | -38,314 |